Why GW Pharmaceuticals (GWPH) Stock Is Rising Today

NEW YORK (TheStreet) -- GW Pharmaceuticals (GWPH) shares are spiking, up 8.1% to $103.98, on Monday after analysts at Piper Jaffray (PJC) drastically increased its price target to $147 from $97.

The improved valuation stems from an analyst's evaluation of the U.K. based pharmaceutical company's cannabinoid based epilepsy treatment, Epidolex.

Analysts Dr. Joshua Schimmer believes that the drug is a "highly attractive" treatment for children suffering from Dravet Syndrome, as children treated with it have fewer seizures and can take lower doses of other medicines.

Must ReadWarren Buffett's 25 Favorite Stocks

GWPH Chart

GWPH data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Wall Street Is Totally Forgetting Apple Will Be Giving Away Tons of Cash in 2018

Wall Street Is Totally Forgetting Apple Will Be Giving Away Tons of Cash in 2018

Tuesday's Premarket Movers: CAT, UTX, KO, MMM

Tuesday's Premarket Movers: CAT, UTX, KO, MMM

Vivendi Slides After Reports Vincent Bollore Questioned in Corruption Probe

Vivendi Slides After Reports Vincent Bollore Questioned in Corruption Probe

Alphabet, Caterpillar, Coca-Cola and Amazon - 5 Things You Must Know

Alphabet, Caterpillar, Coca-Cola and Amazon - 5 Things You Must Know

Alphabet's Earnings Beat and 4 Other Business Stories You Must Know Tuesday

Alphabet's Earnings Beat and 4 Other Business Stories You Must Know Tuesday